Fludrocortisone Tablet 100 mcg Tablet

    Fludrocortisone Tablet 100 mcg

    Fludrocortisone Acetate

    Category: Tablet

    Manufacturer: Renata Limited

    Uses of Fludrocortisone Tablet: - Addison's disease - Congenital adrenal hyperplasia Primary and secondary adrenocortical insufficiency in Addison disease, Salt-Losing Forms of Congenital Adrenogenital Syndrome Hypersensitivity. Hyperalbuminaemia; hypertension, systemic fungal infections.
    Corticosteroid
    Fludrocortisone binds the mineralocorticoid receptor (aldosterone receptor). This binding (or activation of the mineralocorticoid receptor by fludrocortisone) in turn causes an increase in ion and water transport and thus raises extracellular fluid volume and blood pressure and lowers potassium levels.
    How to use Fludrocortisone Acetate: Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Fludrocortisone Acetate is to be taken with food. Adult Dose: Oral Adult: Primary adrenocortical insufficiency Adrenocortical Insufficiency/Addison Disease Primary and secondary adrenocortical insufficiency in Addison disease Usual, 0.1 mg/day PO; range, 0.1 mg PO 3 times weekly to 0.2 mg/day PO If hypertension occurs: 0.05 mg/day PO Salt-Losing Forms of Congenital Adrenogenital Syndrome 0.1-0.2 mg/day PO Child Dose: Not FDA-approved for use in children
    May decrease salicylate levels. Anticholinesterase effects are antagonised. Decreased effects with rifampin, barbiturates, hydantoins and phenytoin. Oral contraceptives or ritonavir may increase the plasma concentrations of fludrocortisone. Increased potassium loss with potassium-depleting drugs e.g. thiazides, furosemide or amphotericin B. Increased risk of GI bleeding or ulceration with NSAIDs. May alter efficacy of anticoagulants when used concurrently.
    Hypersensitivity. Hyperalbuminaemia; hypertension, systemic fungal infections.
    Common - Behavioural changes - Weight gain - Bone disorder - Thinning of skin - Altered blood sugar level - Mood changes - Upset stomach Acne, hypertension, sodium and water retention, potassium loss, dizziness, itching, skin rash, headache, convulsions, CHF, muscle weakness, hyperglycaemia, HPA and growth suppression, peptic ulcer, cataracts, raised intraocular pressure and reduced visual acuity. Insomnia, Menstrual irregularity, Myopathy, Neuritis, Osteoporosis
    Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Fludrocortisone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.Lactation: There are no data on the excretion of fludrocortisone into human milk. However, corticosteroids (systemic therapy) are distributed into breast milk and could cause growth suppression and/or other adverse effects in nursing infants. The manufacturer recommends that caution be used when administering Fludrocortisone to nursing women.
    Precaution: Use with caution in diabetes mellitus, hypertension, hypothyroidism, electrolyte abnormalities, sodium and water retention, infections, immunizations, ocular herpes simplex, myasthenia gravis, peptic ulcer disease, psychosis, renal insufficiency. Prolonged corticosteroid use may result in elevated intraocular pressure, glaucoma, or cataracts and has been associated with development of Kaposi sarcoma Lactation: Unknown whether drug is excreted in milk; use with caution
    Overdose is unlikely; however, treatment of overdose is by supportive and symptomatic therapy.
    Store in a cool and dry place, protected from light.
    Corticosteroid
    Potent mineralocorticoid with high glucocorticoid activity; Fludrocortisone promotes increased reabsorption of sodium and excretion of potassium from renal distal tubules
    Pregnancy category: C Lactation: Unknown whether drug is excreted in milk; use with caution
    Profile avater

    Samm Care